Author

Zijie Zhao

East China University of Science and TechnologyORCID 0009-0004-9482-8315Unclaimed ORCID profile · follow to get notified of new preprints

Additional preprints under this name without ORCID

Zijie Zhao1 paper · Hebei Medical University

Biology Disciplines

Click to filter author papers

Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:mouse· 1 Assay:proteomics· 1 Approach:wet-lab / biochemical assay· 1

Frequent Co-Authors

Cheng LuoiD· 1 shared Chun Li· 1 shared Hewei JiangiD· 1 shared Hong Huang· 1 shared Honglin LiiD· 1 shared Huifang TangiD· 1 shared Huijuan Wang· 1 shared Jian Cui· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperPharmacology & Toxicology

Cheng LuoORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Inhibiting RhoA Activation via GDP-state Stabilization to Relieve Heart Failure

Mengzhu Xue, Yingquan Liang, Zhen Yuan, Xiangning Liu, Longfeng Chang, Yongzhi Wang, Peijia Xu, Tingting Zhang, Hewei Jiang, Zijie Zhao, Jingqiu Liu, Shanshan Ruan, Tianyu Ye, Xuelian Pang, 梅文一, , Honglin Li

This study identifies a compound that inhibits RhoA activation by stabilizing its GDP state, reducing myocardial remodeling and fibrosis in heart failure models.

Circulation Research · Mar 20, 2026Peer-reviewedPharmacology & Toxicology